JBC Connect with Cosmo for Collagen Detection

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M506855200 on September 30, 2005

J. Biol. Chem., Vol. 280, Issue 48, 40097-40103, December 2, 2005
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
280/48/40097    most recent
M506855200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Moreno-Miralles, I.
Right arrow Articles by Hiebert, S. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Moreno-Miralles, I.
Right arrow Articles by Hiebert, S. W.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

The inv(16) Cooperates with ARF Haploinsufficiency to Induce Acute Myeloid Leukemia*

Isabel Moreno-Miralles{ddagger}1, Ling Pan{ddagger}1, Jennifer Keates-Baleeiro{ddagger}§, Kristie Durst-Goodwin{ddagger}, Chunying Yang¶, Hyung-Gyoon Kim||, Mary Ann Thompson**, Christopher A. Klug||, John L. Cleveland¶, and Scott W. Hiebert{ddagger}{ddagger}{ddagger}2

From the {ddagger}Departments of Biochemistry and §Pediatrics, Vanderbilt University School of Medicine, Nashville, Tennessee, 37232 Department of Biochemistry, St. Jude Children's Research Hospital, and Department of Molecular Sciences, University of Tennessee, Memphis, Tennessee, 38105 ||Department of Microbiology, University of Alabama at Birmingham, Birmingham, Alabama, 35294 **Department of Pathology, Vanderbilt University Medical Center, Nashville, Tennessee, and {ddagger}{ddagger}Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee 37232

The inv(16) is one of the most frequent chromosomal translocations associated with acute myeloid leukemia (AML) and creates a chimeric fusion protein consisting of most of the runt-related X1 co-factor, core binding factor {beta} fused to the smooth muscle myosin heavy chain MYH11. Expression of the ARF tumor suppressor is regulated by runt-related X1, suggesting that the inv(16) fusion protein (IFP) may repress ARF expression. We established a murine bone marrow transplant model of the inv(16) in which wild type, Arf+/-, and Arf-/- bone marrow were engineered to express the IFP. IFP expression was sufficient to induce a myelomonocytic AML even when expressed in wild type bone marrow, yet removal of only a single allele of Arf greatly accelerated the disease, indicating that Arf is haploinsufficient for the induction of AML in the presence of the inv(16).


Received for publication, June 23, 2005 , and in revised form, September 26, 2005.

* This work was supported by Vanderbilt-Ingram Cancer Center Grant CA68485 and National Institutes of Health Grants RO1-CA87549, RO1-CA64140, RO1-CA77274 (to S. W. H.) and RO1-CA76379 (to J. L. C.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 These authors contributed equally to this work.

2 To whom correspondence should be addressed: Dept. of Biochemistry, Vanderbilt University School of Medicine, PRB 512, 23rd and Pierce, Nashville, Tennessee 37232. Tel.: 615-936-3582; Fax: 615-936-1790; E-mail: scott.hiebert{at}vanderbilt.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
BloodHome page
H.-G. Kim, K. Kojima, C. S. Swindle, C. V. Cotta, Y. Huo, V. Reddy, and C. A. Klug
FLT3-ITD cooperates with inv(16) to promote progression to acute myeloid leukemia
Blood, February 1, 2008; 111(3): 1567 - 1574.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. Markus, M. T. Garin, J. Bies, N. Galili, A. Raza, M. J. Thirman, M. M. Le Beau, J. D. Rowley, P. P. Liu, and L. Wolff
Methylation-Independent Silencing of the Tumor Suppressor INK4b (p15) by CBF{beta}-SMMHC in Acute Myelogenous Leukemia with inv(16)
Cancer Res., February 1, 2007; 67(3): 992 - 1000.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. Wunderlich, O. Krejci, J. Wei, and J. C. Mulloy
Human CD34+ cells expressing the inv(16) fusion protein exhibit a myelomonocytic phenotype with greatly enhanced proliferative ability
Blood, September 1, 2006; 108(5): 1690 - 1697.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.